Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research
Open accessThe DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Various adverse events resulting from, or associated with, benzodiazepine and/or Z-drug use have been extensively reported on and discussed in great detail within the biomedical literature. It is widely accepted that motor vehicle accidents and falls leading to fractures in older adults are major adverse events that have been shown to occur more frequently in users of sedative-hypnotic medication, especially of the benzodiazepine and related Z-drug variety. However, the last few years have seen increasing reports in the literature raising the issue of benzodiazepine and Z-drug exposure in the development of other serious medical issues including dementia, infections, respiratory disease exacerbation, pancreatitis, and cancer. This article provides an overview and interpretation on the current state of evidence regarding each of these associations and proposes what gaps in the evidence for drug-exposure-harm associations need to be addressed in the future for the purpose of evaluating causality of harm as it relates to these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This was followed by the gradual clinical realization from accumulating evidence and experience that long-term use of BZD cause potential physiologic dependence, cognitive impairment and psychomotor impairment leading to falls and fractures.7, 8, 9”
From Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review (2024) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974 · cited 1×
“A concise summary assessing each adverse outcome association (excluding overdose for obvious reasons) for causality has been provided in Table 1 based on the well recognized Bradford Hill criteria [142], which has been operationalized in pharmacoepidemiology in the past [143].”
MethodInterventions for preventing falls in older people living in the community
Gillespie, L. D., Robertson, M. C., Gillespie, W. J., Sherrington, C., Gates, S., Clemson, L., & Lamb, S. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007146.pub3 · Cited by 3,966
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
Woolcott, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.357 · Cited by 1,326
Excess mortality following hip fracture: a systematic epidemiological review
Abrahamsen, B., van Staa, T., Ariely, R., Olson, M., & Cooper, C. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0920-3 · Cited by 1,079
Global Epidemiology of Dementia: Alzheimer’s and Vascular Types
Rizzi, L., Rosset, I., & Roriz-Cruz, M. (2014) · BioMed Research International · doi:10.1155/2014/908915 · Cited by 751 · cited 1×
“Dementia, comprising Alzheimer’s disease, vascular, Lewy body and other sub-types, remains among the most feared disease states associated with aging because of its poor prognosis, lack of effective treatment modalities, and increasing global prevalence in the aging population [119].”
BackgroundPolydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703 · cited 1×
“Concurrent use of benzodiazepines and opioids, in particular, is a complex topic reviewed in detail elsewhere [72, 73].”
BackgroundMedication as a Risk Factor for Falls: Critical Systematic Review
Hartikainen, S., Lonnroos, E., & Louhivuori, K. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.10.1172 · Cited by 596
Park, T. W., Saitz, R., Ganoczy, D., Ilgen, M. A., & Bohnert, A. S. B. (2015) · BMJ · doi:10.1136/bmj.h2698 · Cited by 579 · cited 1×
“86 for previous prescription and current prescription of benzodiazepines, respectively) [85].”
Background
Research works printed but not linked: 2
- Trevor AJ. Chapter 22: sedative–hypnotic drugs. In: Katzung BG, Trevor AJ, editors. Basic and clinical pharmacology, 13e. New York: McGraw-Hill Medical; 2015. http://mhmedical.com/content.aspx?aid=1104844214 .
- Ben Tsutaoka P. Chapter 31. Benzodiazepines. In: Olson KR, editor. Poisoning and drug overdose, 6e. New York: The McGraw-Hill Companies; 2012. http://mhmedical.com/content.aspx?aid=55975250 .
Cited by
The Technological Impact of COVID-19 on the Future of Education and Health Care Delivery
Shah, S. (2020) · Pain Physician · doi:10.36076/ppj.2020/23/s367 · Cited by 229
“Healthcare System During COVID-19 Pandemic (48)”
Shinjyo, N., Waddell, G., & Green, J. (2020) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x20967323 · Cited by 137
Non-pharmacological Approaches for Management of Insomnia
Chan, N. Y., Chan, J. W. Y., Li, S. X., & Wing, Y. K. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01029-2 · Cited by 135
Understanding buprenorphine for use in chronic pain: expert opinion
Webster, L., Gudin, J., Raffa, R. B., Kuchera, J., Rauck, R., Fudin, J., Adler, J., & Mallick-Searle, T. (2020) · Pain Medicine · doi:10.1093/pm/pnz356 · Cited by 130
“As a caveat, respiratory depression is still a concern, especially when buprenorphine is used in combination with nonopioid sedatives/anticonvulsants such as benzodiazepines and gabapentin [57,58], carisoprodol and other muscle relaxants [59], amitriptyline [60], and Z-drugs (nonbenzodiazepine drugs with effects simil…”
BackgroundKakar, E., Billar, R. J., van Rosmalen, J., Klimek, M., Takkenberg, J. J. M., & Jeekel, J. J. (2021) · Open Heart · doi:10.1136/openhrt-2020-001474 · Cited by 121
Metadata
- Authors
- Brandt, J., & Leong, C.
- Affiliations
- University of Manitoba (CA)
- Corresponding author
- Brandt, Jaden
- Venue
- Drugs in R&D
- Published
- 2017-09-01
- Volume
- 17
- Issue
- 4
- Pages
- 493-507
- ISSN
- 1174-5886 (ISSN-L)
- 1179-6901
- PMC
- PMC5694420
- OpenAlex
- W2751648725
- Cited by
- 356
- References
- 142
- Citations by year
- 2026: 24 · 2025: 36 · 2024: 56 · 2023: 51 · 2022: 38 · 2021: 46 · 2020: 71 · 2019: 19 · 2018: 13
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- Locations
- Drugs in R&D (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- benzodiazepines, Z-drugs, sedative-hypnotic drugs, adverse drug outcomes, dementia, infection, pancreatitis, cancer risk, falls in older adults, motor vehicle accidents
- MeSH terms
- Sleep Aids, Pharmaceutical, Benzodiazepines, Humans, Hypnotics and Sedatives, Biomedical Research, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research. https://app.cochat.ai/papers/10.1007/s40268-017-0207-7
- The paper
- Brandt, J., & Leong, C. (2017). Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research. Drugs in R&D. https://doi.org/10.1007/s40268-017-0207-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.